Mustafa Necmettin ÜNAL, Başak Ceyda MEÇO, Melek TULUNAY, Fatma Handan CUHRUK, Mehmet ORAL

Can plasma-free DNA concentration be a diagnostic tool in critically ill septic patients?

To investigate the diagnostic value of plasma-free DNA concentration (PF-DNA) in septic patients compared to nonseptic patients and to correlate it with clinical outcome. Materials and methods: Forty-two mechanically ventilated consecutive patients (11 septic, 31 nonseptic) admitted to the intensive care unit (ICU) were recruited. On admission, besides PF-DNA concentration, APACHE II and SOFA scores and serum C-reactive protein (CRP), procalcitonin (PCT), and serum lipid concentrations, together with clinical outcome, were assessed. Plasma samples from 11 volunteers were also collected. Appropriate statistics were used for analysis. Results: Median PF-DNA concentrations on admission were significantly higher in septic patients compared to nonseptic patients [14,285 (48-180,311) GE/mL versus 546.5 (0-7674) GE/mL, P < 0.0001]. For distinguishing septic and nonseptic patients on admission, the area under the curve obtained for PF-DNA concentration was 0.9 (sensitivity 84%, specificity 95%; cutoff 4083 GE/mL). There were no significant differences between PF-DNA concentrations of nonsurvivors and survivors. Additionally, DNA concentration demonstrated a significant correlation with CRP, PCT, and high-density lipoprotein concentrations. Conclusion: Plasma DNA seems to be a potentially valuable tool to confirm sepsis diagnosis upon ICU admission.

Anahtar Kelimeler:

Key words: Plasma-free DNA, critical illness, sepsis, diagnosis

Can plasma-free DNA concentration be a diagnostic tool in critically ill septic patients?

Keywords:

Key words: Plasma-free DNA, critical illness, sepsis, diagnosis,

PDF

___

Dellinger RP, Carlet JM, Masaur H, Gerlach H, Calandra T, Cohen J et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32: 858–73. 2. Beutz MA, Abraham E. Community acquired pneumonia and sepsis. Clin Chest Med 2005; 26: 19–28.
Lo YMD, Rainer TH, Chang LYS, Hjelm MN, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46: 319–23.
Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci 2004; 1022: 232–8.
Johnson PJ, Lo YM. Plasma nucleic acids in the diagnosis and management of malignant disease. Clin Chem 2002; 48: 1186– 93.
Şatıroğlu Tufan NL, Tufan AÇ, Kaleli B, Yıldırım B, Semerci NC, Bağcı H. Analysis of cell-free fetal DNA from maternal plasma and serum using a conventional multiplex PCR: factors influencing success. Turk J Med Sci 2005; 35: 85–92.
Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 2001; 313: 139–42.
Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006; 6: 813–22.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure, and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644–55.
Martins GA, Kawamura MT, Carvalho MGC. Detection of DNA in the plasma of septic patients. Ann N Y Acad Sci 2000; 906: 134–40.
Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947–51.
Margraf S, Logters T, Reipen J, Altrichter J, Scholz M, Windolf J. Neutrophil-derived circulating free DNA (cf-DNA/NETs): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock 2008; 30: 352–8.
Saukkonen K, Lakkisto P, Pettilä V, Varpula M, Karlsson S, Ruokonen E et al. Finnsepsis Study Group. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008; 54: 1000–7.
Huttunen R, Kuparinen T, Jylhava J, Aittoniemi J, Vuento R, Hugtala H et al. Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: a prospective cohort study. PLoS One 2011; 6: e21700.
Moreira VG, Prietro B, Rodriguez JS, Alvarez FV. Usefulness of cell-free plasma DNA, procalcitonin and C-reactive protein as markers of infection in febrile patients. Ann Clin Biochem 2010; 47: 253–8.
Lichtenstein AV, Melkonyan HS, Tomei LD, Umansky SR. Circulating nucleic acids and apoptosis. Ann N Y Acad Sci 2001; 945: 239–49.
Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 2002; 18: 487– 94.
Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 2005; 174: 5110–8.
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532–5.
Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005; 11: 473–80.
Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006; 72: 69–80.
Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 2003; 31: 1737–41.
Aktaş Tapısız A, Ergenekon E, Erbaş E, Öktem M, Demirel N, Gücüyener K et al. Interleukin-6 and nitric oxide levels in neonatal sepsis. Turk J Med Sci 2007; 37: 261–6.